The post XRP Surges as First U.S. Spot ETF Debuts on Nasdaq appeared on BitcoinEthereumNews.com. Canary Capital’s XRPC ETF marks a major milestone for Ripple. Ripple’s payment network’s native token, XRP, surged on Thursday following the debut of Canary Capital’s spot XRP exchange-traded fund (ETF), which is trading under the ticker XRPC on the Nasdaq. XRP jumped roughly 5% to $2.50 after the ETF’s launch, before retracing slightly to $2.42, still up 3%, according to The Defiant’s price page. The move builds on week-long momentum, as the token had already rallied nearly 10% over the past seven days amid anticipation for the ETF’s debut. XRP Chart A Ripple Milestone The launch marks the first U.S.-listed spot ETF directly tied to XRP, highlighting the token’s progress toward broader mainstream adoption. In its first 30 minutes of trading, the fund drew approximately $42 million in volume. At the time of writing, XRPC is trading at $25.60, down 3.9% from its opening price of $26.60. The listing follows the U.S. Securities and Exchange Commission’s approval of Canary’s Form 8-A filing earlier this week. BNY Mellon is serving as the fund’s custodian, while Nasdaq will handle daily trading operations. The milestone comes after years of legal and regulatory uncertainty for Ripple, which has spilled over onto XRP. The SEC’s five-year long lawsuit over whether XRP is a security was officially settled earlier this year after appeals were dropped by both parties. Experts told The Defiant at the time that the case signals a shift in the SEC’s approach, moving toward clearer rules instead of relying on enforcement; however, overall U.S. crypto rules still remain uncertain. The Rise of the ETF The Securities and Exchange Commission (SEC) approved the first spot Bitcoin (BTC) ETFs in January 2024, representing a significant moment for the cryptocurrency sector. Bitcoin ETFs currently hold $135.8 billion in total net assets, around 6.67% of Bitcoin’s market… The post XRP Surges as First U.S. Spot ETF Debuts on Nasdaq appeared on BitcoinEthereumNews.com. Canary Capital’s XRPC ETF marks a major milestone for Ripple. Ripple’s payment network’s native token, XRP, surged on Thursday following the debut of Canary Capital’s spot XRP exchange-traded fund (ETF), which is trading under the ticker XRPC on the Nasdaq. XRP jumped roughly 5% to $2.50 after the ETF’s launch, before retracing slightly to $2.42, still up 3%, according to The Defiant’s price page. The move builds on week-long momentum, as the token had already rallied nearly 10% over the past seven days amid anticipation for the ETF’s debut. XRP Chart A Ripple Milestone The launch marks the first U.S.-listed spot ETF directly tied to XRP, highlighting the token’s progress toward broader mainstream adoption. In its first 30 minutes of trading, the fund drew approximately $42 million in volume. At the time of writing, XRPC is trading at $25.60, down 3.9% from its opening price of $26.60. The listing follows the U.S. Securities and Exchange Commission’s approval of Canary’s Form 8-A filing earlier this week. BNY Mellon is serving as the fund’s custodian, while Nasdaq will handle daily trading operations. The milestone comes after years of legal and regulatory uncertainty for Ripple, which has spilled over onto XRP. The SEC’s five-year long lawsuit over whether XRP is a security was officially settled earlier this year after appeals were dropped by both parties. Experts told The Defiant at the time that the case signals a shift in the SEC’s approach, moving toward clearer rules instead of relying on enforcement; however, overall U.S. crypto rules still remain uncertain. The Rise of the ETF The Securities and Exchange Commission (SEC) approved the first spot Bitcoin (BTC) ETFs in January 2024, representing a significant moment for the cryptocurrency sector. Bitcoin ETFs currently hold $135.8 billion in total net assets, around 6.67% of Bitcoin’s market…

XRP Surges as First U.S. Spot ETF Debuts on Nasdaq

Canary Capital’s XRPC ETF marks a major milestone for Ripple.

Ripple’s payment network’s native token, XRP, surged on Thursday following the debut of Canary Capital’s spot XRP exchange-traded fund (ETF), which is trading under the ticker XRPC on the Nasdaq.

XRP jumped roughly 5% to $2.50 after the ETF’s launch, before retracing slightly to $2.42, still up 3%, according to The Defiant’s price page.

The move builds on week-long momentum, as the token had already rallied nearly 10% over the past seven days amid anticipation for the ETF’s debut.

XRP Chart

A Ripple Milestone

The launch marks the first U.S.-listed spot ETF directly tied to XRP, highlighting the token’s progress toward broader mainstream adoption.

In its first 30 minutes of trading, the fund drew approximately $42 million in volume. At the time of writing, XRPC is trading at $25.60, down 3.9% from its opening price of $26.60.

The listing follows the U.S. Securities and Exchange Commission’s approval of Canary’s Form 8-A filing earlier this week. BNY Mellon is serving as the fund’s custodian, while Nasdaq will handle daily trading operations.

The milestone comes after years of legal and regulatory uncertainty for Ripple, which has spilled over onto XRP. The SEC’s five-year long lawsuit over whether XRP is a security was officially settled earlier this year after appeals were dropped by both parties.

Experts told The Defiant at the time that the case signals a shift in the SEC’s approach, moving toward clearer rules instead of relying on enforcement; however, overall U.S. crypto rules still remain uncertain.

The Rise of the ETF

The Securities and Exchange Commission (SEC) approved the first spot Bitcoin (BTC) ETFs in January 2024, representing a significant moment for the cryptocurrency sector. Bitcoin ETFs currently hold $135.8 billion in total net assets, around 6.67% of Bitcoin’s market capitalization.

In July 2024, Ethereum ETFs marked their debut – these funds currently have a total net asset of $22.14 billion, or 5.42% of Ethereum Market Cap.

Most recently, the first U.S.-based Solana ETFs debuted on Oct. 28, with the launch of the Bitwise Solana Staking ETF (BSOL) and the Grayscale Solana Trust (GSOL).

Source: https://thedefiant.io/news/blockchains/xrp-surges-as-first-u-s-spot-etf-debuts-on-nasdaq

Market Opportunity
XRP Logo
XRP Price(XRP)
$2.0636
$2.0636$2.0636
-1.56%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23